EGF Theramed Health Corp.
TMED
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.62% | 12.46% | -6.26% | -17.72% | -37.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.89% | 10.93% | -5.02% | -16.59% | -36.63% |
| Operating Income | -17.89% | -10.93% | 5.02% | 16.59% | 36.63% |
| Income Before Tax | -794.21% | -691.49% | -28.40% | -27.70% | 37.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,102.46% | -966.73% | -29.66% | -28.94% | 37.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 63.70% | -17.50% | 58.54% | 175.93% | 31.53% |
| Net Income | -1,186.43% | -1,065.21% | -27.66% | -22.36% | 39.93% |
| EBIT | -17.89% | -10.93% | 5.02% | 16.59% | 36.63% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1,165.19% | -1,025.42% | -19.25% | -12.89% | 44.76% |
| Normalized Basic EPS | -981.61% | -880.21% | -10.94% | -2.92% | 50.29% |
| EPS Diluted | -1,165.19% | -1,025.42% | -19.25% | -12.89% | 44.76% |
| Normalized Diluted EPS | -981.61% | -880.21% | -10.94% | -2.92% | 50.29% |
| Average Basic Shares Outstanding | 1.66% | 3.43% | 5.03% | 6.70% | 8.44% |
| Average Diluted Shares Outstanding | 1.66% | 3.43% | 5.03% | 6.70% | 8.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |